A detailed history of Pacer Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Pacer Advisors, Inc. holds 1,293,726 shares of JAZZ stock, worth $138 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,293,726
Previous 1,023,706 26.38%
Holding current value
$138 Million
Previous $126 Million 23.73%
% of portfolio
0.4%
Previous 0.4%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$115.19 - $132.77 $31.1 Million - $35.9 Million
270,020 Added 26.38%
1,293,726 $156 Million
Q4 2023

Jan 16, 2024

BUY
$114.26 - $136.0 $25.7 Million - $30.6 Million
224,865 Added 28.15%
1,023,706 $126 Million
Q3 2023

Nov 13, 2023

BUY
$122.0 - $145.31 $14 Million - $16.6 Million
114,552 Added 16.74%
798,841 $103 Million
Q2 2023

Jul 12, 2023

BUY
$122.5 - $147.16 $25.3 Million - $30.4 Million
206,243 Added 43.14%
684,289 $84.8 Million
Q1 2023

May 02, 2023

BUY
$133.98 - $160.47 $18.4 Million - $22.1 Million
137,586 Added 40.41%
478,046 $70 Million
Q4 2022

Feb 06, 2023

BUY
$129.72 - $159.85 $43.8 Million - $54 Million
337,685 Added 12168.83%
340,460 $54.2 Million
Q3 2022

Oct 18, 2022

BUY
$126.59 - $161.18 $351,287 - $447,274
2,775 New
2,775 $370,000
Q1 2022

Apr 05, 2022

SELL
$129.64 - $160.7 $811,546 - $1.01 Million
-6,260 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$119.87 - $145.67 $55,499 - $67,445
-463 Reduced 6.89%
6,260 $798,000
Q3 2021

Oct 15, 2021

SELL
$128.64 - $184.79 $2.08 Million - $2.98 Million
-16,149 Reduced 70.61%
6,723 $875,000
Q2 2021

Jul 21, 2021

BUY
$160.2 - $186.42 $2.65 Million - $3.09 Million
16,567 Added 262.76%
22,872 $4.06 Million
Q1 2021

Apr 05, 2021

BUY
$150.19 - $173.5 $35,895 - $41,466
239 Added 3.94%
6,305 $1.04 Million
Q4 2020

Jan 20, 2021

BUY
$140.71 - $165.05 $853,546 - $1 Million
6,066 New
6,066 $1 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.69B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.